Header cover image

Healthcare Sector

Results

2295

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2295 companies

Gyre Therapeutics

Market Cap: US$696.2m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

GYRE

US$8.22

7D

-19.3%

1Y

-24.4%

Nika Pharmaceuticals

Market Cap: US$667.1m

A pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.

NIKA

US$0.65

7D

0%

1Y

30.5%

Trevi Therapeutics

Market Cap: US$662.4m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

TRVI

US$6.32

7D

0.4%

1Y

147.6%

Anavex Life Sciences

Market Cap: US$645.4m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

AVXL

US$7.84

7D

6.4%

1Y

90.3%

Arbutus Biopharma

Market Cap: US$643.5m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

ABUS

US$3.45

7D

0%

1Y

3.3%

Evolus

Market Cap: US$642.8m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

EOLS

US$9.96

7D

1.5%

1Y

-22.6%

KalVista Pharmaceuticals

Market Cap: US$642.3m

A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

KALV

US$13.35

7D

19.0%

1Y

12.6%

AnaptysBio

Market Cap: US$642.3m

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

ANAB

US$23.52

7D

16.8%

1Y

-0.9%

Cogent Biosciences

Market Cap: US$639.2m

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

COGT

US$5.79

7D

18.6%

1Y

-34.2%

AbCellera Biologics

Market Cap: US$638.8m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

ABCL

US$2.31

7D

16.7%

1Y

-38.9%

RxSight

Market Cap: US$631.1m

A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

RXST

US$15.81

7D

-1.2%

1Y

-72.3%

Fulgent Genetics

Market Cap: US$630.8m

Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

FLGT

US$20.67

7D

1.8%

1Y

-1.0%

Claritev

Market Cap: US$628.7m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

CTEV

US$37.59

7D

37.2%

1Y

99.5%

CeriBell

Market Cap: US$620.9m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

CBLL

US$16.93

7D

-2.0%

1Y

n/a

Curaleaf Holdings

Market Cap: CA$848.2m

Produces and distributes cannabis products in the United States and internationally.

CURA

CA$1.14

7D

-7.3%

1Y

-81.6%

Sionna Therapeutics

Market Cap: US$616.0m

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

SION

US$14.48

7D

10.7%

1Y

n/a

Tian'an Technology Group

Market Cap: US$614.5m

Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.

TANA.F

US$13.50

7D

3.8%

1Y

8,900.0%

Embecta

Market Cap: US$610.7m

A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

EMBC

US$10.61

7D

-5.8%

1Y

-17.4%

ORIC Pharmaceuticals

Market Cap: US$602.1m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

ORIC

US$8.40

7D

45.3%

1Y

-3.0%

Regulus Therapeutics

Market Cap: US$600.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

RGLS

US$7.97

7D

0.8%

1Y

260.6%

Taysha Gene Therapies

Market Cap: US$597.8m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

TSHA

US$2.78

7D

6.7%

1Y

-24.5%

Advanced Medical Solutions Group

Market Cap: UK£441.0m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

AMS

UK£2.07

7D

4.5%

1Y

-2.1%

Keros Therapeutics

Market Cap: US$595.4m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

KROS

US$14.95

7D

4.2%

1Y

-69.8%

Bicycle Therapeutics

Market Cap: US$592.1m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

BCYC

US$8.30

7D

3.4%

1Y

-63.5%

Iovance Biotherapeutics

Market Cap: US$587.7m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

IOVA

US$1.82

7D

5.2%

1Y

-77.5%

LifeMD

Market Cap: US$584.0m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

LFMD

US$12.65

7D

9.6%

1Y

68.0%

Integral Diagnostics

Market Cap: AU$900.8m

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

IDX

AU$2.42

7D

1.7%

1Y

2.1%

Upstream Bio

Market Cap: US$573.4m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

UPB

US$10.84

7D

12.7%

1Y

n/a

Butterfly Network

Market Cap: US$571.2m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

BFLY

US$2.36

7D

-6.7%

1Y

155.3%

Elite Pharmaceuticals

Market Cap: US$570.7m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

ELTP

US$0.54

7D

1.4%

1Y

226.7%

Xencor

Market Cap: US$569.4m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

XNCR

US$8.58

7D

13.3%

1Y

-64.2%

Delcath Systems

Market Cap: US$567.7m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

DCTH

US$16.08

7D

-2.0%

1Y

149.3%

Mind Medicine (MindMed)

Market Cap: US$565.1m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

MNMD

US$7.69

7D

7.7%

1Y

-6.8%

PolyNovo

Market Cap: AU$873.9m

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

PNV

AU$1.27

7D

-1.6%

1Y

-41.7%

Dianthus Therapeutics

Market Cap: US$563.8m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

DNTH

US$17.59

7D

-1.9%

1Y

-19.1%

Talkspace

Market Cap: US$560.5m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

TALK

US$3.41

7D

15.6%

1Y

32.2%

Page 11 of 64